Search

everythinglearnresearchcommunity

for

Search:↓

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Finasteride can treat prostatic haematuria, but its use is controversial.

Generic drugs for benign prostatic hyperplasia can cost up to 500% more at chain pharmacies compared to independent ones.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.

*Laportea bulbifera* contains unique compounds that may help treat benign prostatic hyperplasia.

Saw Palmetto is a safe and effective natural remedy for treating benign prostatic hyperplasia (BPH).

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Finasteride, a drug that prevents testosterone conversion, can effectively reduce blood loss in prostate surgery, especially for patients with a prostatic volume over 30 cc, and decrease post-surgery complications.

Prostate cancer was a major health issue in 2009, especially for Black men, and targeting the 5alpha-reductase enzyme could help in its prevention and treatment.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Bimatoprost is a safe and effective treatment for making eyelashes longer, thicker, and darker.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Antiandrogens help treat hormone-related conditions in both men and women.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Finasteride can cause enlarged breasts.

Adding cerium(III) chloride to Grignard reagents improves the making of compounds that could treat prostate issues and hair loss.

Cyproterone acetate can cause rare shortness of breath in women.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Bimatoprost 0.03% solution effectively promotes eyebrow growth.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Alopecia should be treated as a medical condition because it may increase the risk of serious diseases and psychological issues.